Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Revisiting Richter transformation in the era of novel CLL agents
Anna Petráčková, Peter Turcsányi, Tomáš Papajík, et al.
Blood Reviews (2021) Vol. 49, pp. 100824-100824
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 trial
Constantine S. Tam, Jennifer R. Brown, Brad S. Kahl, et al.
The Lancet Oncology (2022) Vol. 23, Iss. 8, pp. 1031-1043
Closed Access | Times Cited: 178
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway
Smith Rjh, Jan A. Burger
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
Updates on the Treatment of Richter’s Syndrome, Including Novel Combination Approaches
Tushar Jain, Benjamin Heyman
Cancers (2025) Vol. 17, Iss. 6, pp. 943-943
Open Access
Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents
Tamar Tadmor, Ilana Levy
Cancers (2021) Vol. 13, Iss. 20, pp. 5141-5141
Open Access | Times Cited: 21
Emerging Therapies for the Management of Richter Transformation
Elizabeth Smyth, Toby A. Eyre, Chan Y. Cheah
Journal of Clinical Oncology (2022) Vol. 41, Iss. 2, pp. 395-409
Closed Access | Times Cited: 15
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd‐Sokołowska, Ewa Paszkiewicz‐Kozik, et al.
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 2119-2126
Open Access | Times Cited: 7
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and B-cell prolymphocytic leukemia: Report from the 2021 SH/EAHP Workshop
Magdalena Czader, Catalina Amador, James R. Cook, et al.
American Journal of Clinical Pathology (2023) Vol. 159, Iss. 6, pp. 554-571
Open Access | Times Cited: 5
Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper
Toby A. Eyre, John C. Riches, Piers Patten, et al.
British Journal of Haematology (2021) Vol. 196, Iss. 4, pp. 864-870
Open Access | Times Cited: 11
Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?
Hadiyah Y. Audil, Samuel Kosydar, Daniel P. Larson, et al.
Current Hematologic Malignancy Reports (2023) Vol. 18, Iss. 5, pp. 144-157
Closed Access | Times Cited: 4
From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia
Pau Abrisqueta, Ferran Nadeu, Jan Bosch‐Schips, et al.
Cancer Treatment Reviews (2023) Vol. 120, pp. 102619-102619
Open Access | Times Cited: 4
Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience
Shuchao Qin, Rui Jiang, Luomengjia Dai, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1635-1642
Open Access | Times Cited: 1
Decreased apoptotic priming and loss of BCL-2 dependence are functional hallmarks of Richter’s syndrome
Antonella Rigo, Tiziana Vaisitti, Carlo Laudanna, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 1
Central nervous system involvement in chronic lymphocytic leukemia: a case report and review of literature
Li-Yuan Qin, Geng Ye, Jian-Feng Mu, et al.
Journal of Medical Case Reports (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1
In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies
Matylda Kubacz, Aleksandra Kusowska, Magdalena Winiarska, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 235-235
Open Access | Times Cited: 6
Characteristics and outcomes of patients with CLL and CDKN2A/B deletion by fluorescence in situ hybridization
Samantha Teierle, Ying Huang, Adam S. Kittai, et al.
Blood Advances (2023) Vol. 7, Iss. 23, pp. 7239-7242
Open Access | Times Cited: 3
Long non-coding RNA (LncRNA) CHROMR promotes the expression of the CNNM1 gene by adsorbing hsa-miR-1299 to obtain drug resistance in diffuse large B lymphoma cells
Mingyue Wang, Zhichao Miao, Cen Hong, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 5, pp. 1362-1371
Open Access | Times Cited: 4
Conventional chemotherapy: millions of cures, unresolved therapeutic index
Anthony Letai, Hugues de Thé
Nature reviews. Cancer (2024)
Closed Access
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases
Enrico Derenzini, Alessandro Cignetti, Valentina Tabanelli, et al.
Hematology Reports (2024) Vol. 16, Iss. 4, pp. 795-803
Open Access
Vitamin D Deficiency-Associated Comorbidities: A Protein Network Dynamics Perspective
Anton F. Fliri, Shama Kajiji
Medical Research Archives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 1
A Rare Entity of Accelerated Chronic Lymphocytic Leukemia: A Report of Two Cases and Review of Literature
Kmira Zahra, Ben Yahya Noura, Chembah Wafa, et al.
Health (2023) Vol. 15, Iss. 08, pp. 861-870
Open Access | Times Cited: 1
A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation
Kosuke Miki, Reiki Ogasawara, Shunsuke Sugimura, et al.
International Journal of Hematology (2023) Vol. 118, Iss. 6, pp. 766-771
Closed Access | Times Cited: 1
Cytogenomic features of Richter transformation
Renata Woroniecka, Grzegorz Rymkiewicz, Zbigniew Bystydzieński, et al.
Molecular Cytogenetics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Clinical utility of chromosomal microarray in establishing clonality and high risk features in patients with Richter transformation
Brian T. Hess, James Kalmuk, Iya Znoyko, et al.
Cancer Genetics (2021) Vol. 260-261, pp. 18-22
Open Access | Times Cited: 2
[Clonality relatedness and molecular characteristics of Richter transformation].
Yeqin Sha, Rui Jiang, Yi Miao, et al.
PubMed (2022) Vol. 43, Iss. 10, pp. 841-847
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top